Does SIMVASTATIN Cause Activated partial thromboplastin time prolonged? 94 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 94 reports of Activated partial thromboplastin time prolonged have been filed in association with SIMVASTATIN (Simvastatin). This represents 0.4% of all adverse event reports for SIMVASTATIN.
94
Reports of Activated partial thromboplastin time prolonged with SIMVASTATIN
0.4%
of all SIMVASTATIN reports
72
Deaths
87
Hospitalizations
How Dangerous Is Activated partial thromboplastin time prolonged From SIMVASTATIN?
Of the 94 reports, 72 (76.6%) resulted in death, 87 (92.6%) required hospitalization, and 69 (73.4%) were considered life-threatening.
Is Activated partial thromboplastin time prolonged Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIMVASTATIN. However, 94 reports have been filed with the FAERS database.
What Other Side Effects Does SIMVASTATIN Cause?
Myalgia (3,919)
Fatigue (2,066)
Arthralgia (1,775)
Drug interaction (1,744)
Nausea (1,676)
Rhabdomyolysis (1,616)
Dyspnoea (1,542)
Headache (1,470)
Drug hypersensitivity (1,433)
Muscular weakness (1,356)
What Other Drugs Cause Activated partial thromboplastin time prolonged?
DABIGATRAN ETEXILATE (264)
HEPARIN (225)
RIVAROXABAN (163)
WARFARIN (146)
ACETAMINOPHEN (119)
ALLOPURINOL (110)
AMIODARONE (99)
METRONIDAZOLE (98)
DARBEPOETIN ALFA (93)
ASPIRIN (87)
Which SIMVASTATIN Alternatives Have Lower Activated partial thromboplastin time prolonged Risk?
SIMVASTATIN vs SINGULAIR
SIMVASTATIN vs SINTILIMAB
SIMVASTATIN vs SIPONIMOD
SIMVASTATIN vs SIPULEUCEL-T
SIMVASTATIN vs SIROLIMUS